Viral Hepatitis C - Clinical Trial Results Show That Peregrine's First-In-Class Anti-Viral

Clinical Trial Results Show That Peregrine's First-In-Class Anti-Viral
Medical News Today - Peregrine Pharmaceuticals, Inc. (PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it will present top line data demonstrating that its first-in

Vertex Pharmaceuticals
Forbes - Deutsche Bank Securities initiated coverage of Vertex Pharmaceuticals with a "buy' rating and said the development-stage drug company's promising experimental drug candidate VX-950 has "gold standard" potential as a hepatitis C treatment. "Despite a

Third Wave, Chiron, Bayer dismiss HCV patent suit
Reuters UK - CHICAGO (Reuters) - Third Wave Technologies Inc. on Thursday said it reached an agreement with Chiron Corp. and Bayer Corp. to dismiss its lawsuit against Chiron and Bayer over patents related to hepatitis C virus, or HCV. Terms of the agreement were

Aethlon Medical Expands Device Pipeline to Include the Treatment of
Genetic Engineering News - Aethlon Medical plans to combine the core principles of its Hemopurifier platform technology with intellectual property developed by researchers at Boston University as a means to help prevent the spread of cancer following surgery. When cancer has

People With Chronic Hepatitis B To Benefit From Guidance On New Drugs
Medical News Today - The National Institute for Health and Clinical Excellence (NICE) has today issued guidance for the NHS in England and Wales recommending the use of two new drugs for treating hepatitis B. The guidance states that : - - - - Peginterferon alfa-2a is